ClearPoint Neuro Inc vs Gogoro Inc — how do they compare? ClearPoint Neuro Inc trades at $15.86 (market cap $478.63M), while Gogoro Inc trades at $3.93 (market cap $76.98M). The key difference: ClearPoint Neuro Inc is far larger — about 6.2× Gogoro Inc's market cap, and ClearPoint Neuro Inc is trading nearer its 52-week high, Gogoro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | GGR | |
|---|---|---|
Market Cap | $478.63M | $76.98M |
Sector | Health | Technology |
52-Week High | $29.60 | $7.89 |
52-Week Low | $8.66 | $2.74 |
Enterprise Value | $506.63M | $379.42M |
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $16.51, down 5.66% on the day, with a bullish technical signal from moving averages but negative profitability. The company reported record Q1 2026 revenue of $36.97M with 25% organic device growth, though it missed EPS estimates with a $0.32 loss. Recent FDA clearance for the Velocity Alpha surgical drill and a partnership with Sungkyunkwan University highlight expansion efforts in neurosurgical navigation and drug delivery.
Outlook remains speculative with 100% analyst buy ratings anticipating gene therapy commercialization upside, but high execution and regulatory risks persist amid consistent losses and negative margins. The stock's valuation at 11.31x sales reflects growth expectations, yet cash burn from operations requires careful monitoring of financing sustainability.
No Aura AI signal available yet.
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Gogoro is a global technology leader in battery-swapping ecosystems for electric two-wheelers. It provides smart, sustainable urban mobility solutions and manages an extensive network of battery stations.
Read more on GGR →